Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 13/20 | 1.00 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.64 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.61 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL992837 | 0.89 | MAOB (1.00) | MAOBPARP10NR4A2 | |
| SCHEMBL69512 | 0.88 | MAOB (0.78) | MAOBTAAR1PARP10NR4A2 | |
| Hydrochloric Acid SCHEMBL21313331 | 0.87 | MAOB (1.00) | MAOBPARP10NR4A2 | |
| SCHEMBL29638127 | 0.85 | MAOB (1.00) | MAOBPARP10NR4A2 | |
| SCHEMBL1379497 | 0.85 | MAOB (1.00) | MAOBPARP10NR4A2 | |
| SCHEMBL4425903 | 0.84 | MAOB (0.73) | MAOBPARP10NR4A2 | |
| Hydrochloric Acid SCHEMBL2197705 | 0.84 | MAOB (1.00) | MAOBPARP10NR4A2 | |
| SCHEMBL27521276 | 0.83 | MAOB (0.77) | MAOBPARP10NR4A2 | |
| SCHEMBL13886606 | 0.82 | MAOB (0.96) | MAOBTAAR1 | |
| SCHEMBL9627930 | 0.81 | MAOB (0.68) | MAOBPARP10NR4A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9181182-B2 | S1P receptors modulators | AKAAL PHARMA PTY LTD (AU) | 2015-11-10 | — | — | US | disclosed |
| US-20120034270-A1 | S1P Receptors Modulators | AKAAL PHARMA PTY LTD (AU) | 2012-02-09 | — | — | US | disclosed |
| EP-2344446-A1 | S1P RECEPTORS MODULATORS | Akaal Pharma Pty Ltd (AU) | 2011-07-20 | — | — | EP | disclosed |
| WO-2010042998-A1 | S1P RECEPTORS MODULATORS | AKAAL PHARMA PTY LTD (AU) | 2010-04-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120034270-A1 | S1P Receptors Modulators | S1PR1, S1PR5, S1PR3 | MAOB 4070/4885TAAR1 526/4885PARP10 385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.